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Abstract
Background: Implications of donor milk feedings on infant growth in resource limited settings remain uncertain.
This knowledge gap includes the impact of donor milk availability on infant intake of mother’s own milk. Therefore,
this investigation aimed to measure intake and growth in infants receiving donor milk when born to women from
resource limited backgrounds with high rates of human immunodeficiency virus (HIV).
Methods: A retrospective cohort study enrolled eligible infants admitted to a South African combined neonatal
intensive and secondary high care unit, within a one year admission period during 2015, with signed consent for
donor milk feedings. A certified milk bank provided donor milk. Daily nutritional intake during the first month was
recorded. Details included proportional intake of donor milk, mother’s own milk and infant formula. The primary
outcome of infant growth velocity from day back to birth weight to discharge was calculated when length of stay
was ≥14 days. Analyses primarily used T-tests; mixed effects models compared weekly calorie intake.
Results: One hundred five infants with donor milk consent were born at 30.9 ± 3.6 weeks of gestation, weighing
1389 ± 708 g. Forty percent of mothers had HIV. Infant growth velocity did not differ based on percent of feedings
as donor milk (≥ 50%: 11.8 ± 4.9 g/kg/d; < 50%: 13.5 ± 5.3 g/kg/d; p = 0.3). Percent of feedings from donor milk was
similar based on maternal HIV status (positive: 31 ± 25%; negative: 36 ± 29%; p = 0.4), as was percent of feedings as
mother’s milk (positive: 53 ± 35%; negative: 58 ± 30%; p = 0.4). Calorie intake increased markedly during the first two
weeks and then plateaued (p < 0.0001).
Conclusions: Donor milk feedings in higher proportions did not further impair growth of infants managed in a
South African combined neonatal intensive and secondary high care unit with growth rates already below
reference ranges. The provision of donor milk contributed to feedings being composed of primarily human milk
during the first month. Increasing early calorie intake may improve infant growth in this center.
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Background
Pasteurized donor milk (DM) availability in South Afri-
can hospitals has increased substantially during the last
twenty years with the establishment of the Human Milk
Banking Association of South Africa (HMBASA) [1].
Low-cost technology supports pasteurization in resource
limited settings [2]. Increased access to DM through
these milk banks coincides with recommendations that
DM be provided to preterm and low birth weight infants
when a mother’s own milk (MOM) is not available or
sufficient for feedings [3, 4]. Donor milk availability can
allow feedings of critically ill infants born to women in
resource limited settings and with high rates of human
immunodeficiency virus (HIV) to be predominantly
composed of human milk [5]. Its use should be expected
to occur simultaneously with lactation support given a
priority for providing MOM [6, 7].
Using DM in place of formula in conjunction with
mother’s milk reduced the risk of prematurity associated
morbidities including necrotizing enterocolitis (NEC)
and acute and chronic respiratory disorders, although
not in all situations [8–12]. Heating milk alters its com-
position. Loss of bile salt-stimulated lipase activity,
which occurs during any heating method, reduces infant
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fat absorption [13]. Trace elements, growth factors and
cytokines are preserved during pasteurization [14, 15].
However, bioactive hormones including insulin and adi-
ponectin are reduced [16], as may be oligosaccharides
depending on the heating method [17]. The cumulative
impact of these alterations on infant health, including
growth patterns, remains unclear.
The relative proportions of DM versus MOM used for
feedings influence clinical outcomes resulting from DM
exposure [18]. Insufficient research has evaluated the im-
pact of DM feedings on the outcomes of hospitalized in-
fants in resource limited settings with high rates of
maternal HIV. Identifying any impact on infant growth
and implications of DM availability on volumes of MOM
fed to high-risk infants would establish important founda-
tions upon which nutrition provided to these infants may
be improved. Thus, we aimed to measure growth in
high-risk infants exposed to DM and the associated nutri-
tional intake patterns when cared for in a sub-Saharan
secondary care center managing women from a resource
limited background with a high burden of HIV.
Methods
Study design
A single center, retrospective study measured infant
growth as related to DM exposure during a one-year ad-
mission period within which no significant changes in
standards of clinical care occurred. As a secondary care
center, Mowbray Maternity Hospital (MMH) in Cape
Town, South Africa serves disadvantaged women from
the immediate referral area surrounding the hospital. In
addition, MMH serves women referred from level one
facilities including Midwife Obstetric Units, which are
midwife-run primary public care centers for those un-
able to buy private insurance. The neonatal unit (NU)
contains 73 beds, six of which are tertiary care beds and
the rest designated as secondary care. One attending
neonatologist and two attending pediatricians perform
clinical duties daily.
Medical records of infants admitted between January 1,
2015 and December 31, 2015 were screened for eligibility.
Eligibility was defined as having a signed consent form for
DM feedings. All eligible infants had a copy of this signed
consent form permitting use of DM feedings located in
both the medical record and a separate satellite main-
tained by the DM bank, Milk Matters. Exclusion criteria
included a major congenital anomaly or aneuploidy.
Donor milk and nutrition management
The MMH NU standards for nutrition management
have remained consistent prior to, during and since the
study period. A priority in the MMH NU is to prescribe
human milk feedings, either MOM or DM. Feeds are
initiated on Day 0–1, with colostrum and trophic feeds
as available. Feeding initiation volumes range 60–
100 ml/kg/d with daily advancements of 20–30 ml/kg/d
to a maximum of 160 ml/kg/d in term infants and
200 ml/kg/d in preterm infants. Feedings are held or the
rate of advancement lowered for signs of gastrointestinal
distress, including emesis and abdominal distension. Pre-
term infant feedings of expressed milk have human milk
fortifier added after infants achieve full feeding volumes.
For those infants not tolerating feeds by 48–72 h of age,
parenteral nutrition (PN) may be initiated, although un-
commonly given insufficient resources for safety moni-
toring of intravenous infusions.
Milk Matters, a member of HMBASA, provides DM
to the MMH NU. Milk Matters uses the Holder
pasteurization method involving heating milk to 62.5 °C
for 30 min and cooling to 4 °C over 60 min for a total
pasteurization cycle time of 120 min. Any mother’s milk
expressed at the hospital and stored for future use also
undergoes Holder pasteurization, regardless of HIV sta-
tus. Mothers may also express milk for immediate use or
breastfeed the infant at the bedside. If a mother is HIV
positive and expresses a small amount of milk at the
bedside for immediate use, the milk undergoes flash
pasteurization prior to use for feeding. Flash pasteurized
milk is rapidly boiled in a glass jar within a water bath.
For infants able to feed by mouth and born to HIV nega-
tive women, expressed milk may be provided via cup
feeding or infants may breastfeed.
Eligibility for DM feedings requires fulfillment of at least
one infant and one maternal criterion. Infant criteria in-
clude: 1) prematurity (birth weight < 1500 g), 2) recom-
mencement of feedings after surgery or ‘abdominal
mischief,’ or 3) preterm or ill infants born to HIV positive
women. Maternal criteria for mothers of qualifying infants
as detailed above are 1) insufficient supply of expressed
human milk due to breast surgery or illness 2) insufficient
supply during 1st-3rd day postpartum in spite of ongoing
efforts at milk expression, or 3) a contraindication to using
own milk (chemotherapy, serious maternal substance
abuse). When criteria are met, parents are informed of the
option for DM and then written, informed consent is ob-
tained prior to implementing DM feedings. Although the
hospital purchases DM, families are not informed of the
cost or asked to pay for DM. Appropriateness of DM feed-
ings is reevaluated every two weeks and a new consent
form signed indicating the continued need and fulfillment
of criteria. When infants no longer fulfill criteria, MMH
transitions infants to preterm formula if needed. Milk
Matters stores copies of the consents for DM at a satellite
location for at least 10 years.
Outcomes
The primary outcome was infant growth velocity (GV)
from day back to birth weight through discharge,
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calculated using the exponential model [19]. Routine an-
thropometric monitoring in the MMH NU included re-
cording daily weight and weekly head circumference.
Infant lengths were not routinely recorded due to con-
cerns about accuracy of the measurement and high pa-
tient volume. Standard deviation (Z) scores, gender
specific, were calculated based on gestational age at birth
and postmenstrual age at discharge using the Fenton
growth curves for reference [20].
The recorded details of infant feedings included: indi-
cations for prescribing DM, types of feedings prescribed
throughout hospitalization, and daily feeding intake (ac-
tual amounts received, not prescribed) for the first
28 days or through discharge if earlier. Additional char-
acteristics abstracted from medical records included ma-
ternal demographics and infant descriptors: maternal
age and HIV status, disorders of pregnancy, mode of de-
livery, infant inborn status, prevalence of infant morbid-
ities acquired during hospitalization (e.g. sepsis,
respiratory disease, abdominal mischief/NEC), infant
length of stay (LOS) and mortality.
Statistical analysis
Infant GV between the day back to birth weight and dis-
charge was calculated for infants whose LOS lasted
≥14 days. Subgroup analyses were performed for very
low birth weight (VLBW) infants and by whether infants
were born prior to 32 weeks of gestation. Mixed effects
models compared infant weekly volume and energy in-
take. Energy content of unfortified human milk was as-
sumed to be 67 kcal/dL [21]. Standard summary
statistics were calculated for all variables as appropriate
and all analyses were performed using SAS 9.4.
Two-sample t-tests were used to compare growth and
nutrition measures between groups.
Results
Donor milk consent existed for one hundred five infants
during the study period (Table 1). Amongst mothers of
these infants (n = 99; 27.9 ± 6.3 years old), 40 % were
HIV positive (Table 1). Infant birth weight differed by
maternal HIV status (HIV positive: 1790 ± 859 g; HIV
negative: 1109 ± 390 g; p < 0.001). The most common in-
fant indication for prescribing DM was prematurity
(Table 2). Noteworthy infant outcomes included low
rates of NEC and infrequent use of PN (Table 1).
Infant growth
Seventy six infants were hospitalized ≥14 days and 64
had day back to birth weight accurately recorded in the
medical record. For those infants, GV through discharge
was 13.1 ± 5.2 g/kg/d; this rate was similar for infants
whether they were born prior to the 32nd week or later
(p = 0.99). Weight Z scores decreased from birth to
discharge (ΔZ: − 1.46 ± 0.76) as did head circumference
Z scores (− 0.47 ± 0.98). Most of these infants were
VLBW (n = 56) and their GV was 13.8 ± 4.4 g/kg/d.
Growth velocity was similar whether infants received
more or less than 50% of their feeds as DM during the
first month (Table 3). Infant GV did not differ by mater-
nal HIV status (Table 3).
Infant nutrition
Amongst infants discharged from the NU, 95% received
MOM, 95% received DM and 50% received preterm in-
fant formula at any time during hospitalization. For in-
fants receiving < 50% of feeds as DM, the proportion of
feedings as DM was 21 ± 15% in the first month. Con-
versely, for those receiving predominantly DM, the pro-
portion of feedings as DM was 74 ± 16%. The median
percentage of feedings as any human milk during the
Table 1 Demographic characteristics of mothers and infants
Maternal characteristics (N = 99) N (%)a
Antenatal care 65 (73)
Primigravid 19 (21)
HIV Infection 40 (40)
Active tuberculosis 3 (3)
Gestational proteinuric hypertension 17 (19)
Gestational diabetes 0
Substance abuse during pregnancy 32 (35)
Multiple gestation pregnancy 18 (20)
Antenatal steroids 38 (41)
Chorioamnionitis 10 (11)
Cesarean delivery 43 (48)
Infant characteristics (N = 105) Mean ± SD or N (%)
Gestational age, weeks 30.9 ± 3.6
Birth weight, grams 1389 ± 708
Inbornb 68 (69)
Male gender 49 (50)
Respiratory distress syndrome 43 (44)
Patent ductus arteriosus 17 (18)
Surfactant administration 29 (30)
Intraventricular hemorrhage 23 (27)
Infection 21 (22)
Infant characteristics N (%)
Necrotizing enterocolitis 3 (3)
Any total parenteral nutrition use 4 (5)
Mortality during admission 10 (10)
aMissing values range n = 7–10 for maternal characteristics, excluding HIV
infection, and n = 7–9 for infant characteristics aside from intraventricular
hemorrhage (n = 21 missing) and parenteral nutrition use (n = 20 missing);
percentages reported reflect available information
bRefers to infants born at Mowbray Maternity Hospital, as opposed to infants
born elsewhere and then transferred to the neonatal unit for ongoing care
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first month for discharged infants was high (100, IQR
93,100) and proportions of feedings as MOM versus DM
did not appear to be impacted by maternal HIV status
(Table 4). Only five infants were fed MOM exclusively
throughout hospitalization. Eighty five percent of dis-
charged infants received human milk fortifier for some
feedings. For infants with a LOS ≥ 14 days, feeding vol-
umes and calorie intake showed significant increases
during the first two weeks and then consistent intake
during the remainder of the first month, and gestational
age did not appear to modify this association when com-
paring infants born prior to the 32nd week or later (p >
0.1) (Table 5). For VLBW infants hospitalized for over
two weeks (n = 63), mean calorie intake during the first
month was 111 ± 17 kcal/kg/d.
Discussion
While concern remains that DM feedings negatively im-
pact growth for human milk-fed infants, this analysis
suggests that increasing amounts of DM to > 50% of
feedings in the first month does not slow infant growth.
However, it is noteworthy that the GV of all infants in
this South African cohort falls below fetal reference
ranges [22]. For those infants with a signed consent in
the MMH NU, DM availability facilitated high rates of
feedings as human milk during the first 28 days. We de-
tected no difference in GV related to maternal HIV sta-
tus. We believe the difference in infant characteristics,
including birth weight, based on maternal HIV status to
be a consequence of infant inclusion criteria for DM at
MMH. Infants of mothers with HIV may receive DM
while an infant with a comparable degree of illness, born
to a mother without HIV, might not qualify. Specifically,
an ill infant born to a mother with HIV could receive
DM while DM would not be used for the ill infant born
to a mother without HIV if sufficient MOM were avail-
able. In a population of women with high rates of HIV
infection, DM availability did not appear to decrease
amounts of MOM fed to their infants. Availability of
DM has previously improved rates of breastfeeding at
discharge [9].
Implementation and acceptance of DM feedings in com-
munities with high rates of maternal HIV and other clin-
ical settings appears feasible [23]. Still, clinician sensitivity
to women’s concerns towards use of DM feedings is im-
portant. Parents relay concerns about disease transmission
through milk, including HIV, yet increasing parental
familiarity with screening and pasteurization processes
may reduce such concern [23]. Independent of safety con-
cerns, using DM creates stress for many mothers resulting
from the need to rely on milk expressed from other
women [24]. Without surprise, affording parents sufficient
time and opportunities to discuss DM with clinicians
helps clarify misunderstandings and may ease concerns.
As families continue to consider DM as a viable option for
feedings, detailing growth and outcomes for infants using
Table 2 Indications for prescribing donor milk to infants (N = 105)
Infant Criteria N (%)
Preterm infant (< 1500 g) 75 (71)
Recommencement of feeds for babies after surgery
or with ‘abdominal mischief’
11 (10)
Preterm or ill babies of HIV infected mothers 31 (30)
Maternal Criteria for Infant Eligibility
Insufficient supply of mother’s own milk due to
breast surgery or illness
42 (40)
Building up own supply 1st-3rd days post
partum when pasteurizing
34 (32)
Transportation or financial difficulties and no
rooming is available
19 (18)
Contraindications to using own milk
(chemotherapy, serious maternal substance abuse)
1 (1)
Note: More than one indication may apply
Table 3 Growth of discharged infants with admission ≥14 days,
values reported as mean ± sd







All discharged infants n = 48 n = 16 0.3
13.5 ± 5.3 11.8 ± 4.9
Discharged very low birth
weight infants
n = 41 n = 15 0.2
14.3 ± 4.7 12.7 ± 3.4
Growth Velocity by
Maternal HIV Status
No HIV Infection HIV Infection
All discharged infants n = 42 n = 22 0.6
13.4 ± 4.3 12.6 ± 6.7
Discharged very low
birth weight infants
n = 42 n = 14 0.1
13.4 ± 4.3 15.3 ± 4.6
Table 4 Distribution of Milk Intake by Maternal HIV Status,






All discharged infantsa n = 52 n = 34
Percentage of feedings as mother’s
own milk during first 28 days
58 ± 30 53 ± 35 0.4
Percentage of feedings as donor
milk during first 28 days
36 ± 29 30 ± 25 0.4
Discharged very low birth weight infants n = 48 n = 15
Percentage of feedings as mother’s
own milk during first 28 days
58 ± 30 67 ± 31 0.3
Percentage of feedings as donor
milk during first 28 days
37 ± 30 28 ± 27 0.3
aMissing data for n = 9
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DM in sub-Saharan Africa is also necessary for improving
infant care.
Donor milk feedings should not be singled out as the
sole contributor to the measured GV of these infants.
Prompt initiation, advancement and fortification of feed-
ings contributed to a weekly caloric intake that ultim-
ately exceeded recommendations [21], yet not until after
the first week. Also, as VLBW infants made up a consid-
erable proportion of this cohort, average caloric intake
suggests that infants with larger birth weights achieve
higher caloric intake than smaller infants. Thus, early
caloric intake appears to be a modifiable factor in efforts
aimed at improving growth. Early PN is a commonly
used method for minimizing early caloric deficits [25].
However, resources and personnel required to maintain
safe intravenous infusions currently precludes the use of
PN in many infants. Protein concentrations in DM, even
when combined with human milk fortifiers, may not
meet estimated requirements [21, 26]. Also, in consider-
ation of the standards for processing human milk used
in the MMH NU, much of the milk used (any DM, all
stored MOM regardless of a mother’s HIV status and all
expressed milk from HIV positive mothers) undergoes
some method of heating prior to infant feeding. In
addition, the preterm infant’s endogenous lipase capabil-
ities are limited [27]. Cumulatively, these combined fac-
tors would be expected to exacerbate fat malabsorption
as opposed to other clinical scenarios where MOM is
not heated. Access to a safe adjuvant to facilitate fat ab-
sorption would be expected to mitigate the poor growth
observed in comparable populations, however, a
well-tolerated option is not currently available [28].
Delayed availability of MOM was the most common
maternal indication for DM feedings. This is consistent
with other reports [1]. Delayed onset of lactation after
preterm delivery is not uncommon [29]. In this context,
the establishment of DM availability for preterm infants
during insufficient supply of MOM is consistent with
global public health recommendations [3, 4]. Indicators
such as rates of breastfeeding at time of discharge from
neonatal units suggest DM availability may improve use
of MOM [9, 30], but in some scenarios it appears to
hinder intake of MOM [30]. It is possible that discus-
sions of DM with parents emphasize the importance of
human milk for feedings, and when combined with lac-
tation support, increased intake of MOM should be ex-
pected in some settings [31]. Thus, ongoing lactation
support is critical for women who deliver critically ill,
preterm infants and for women who may be temporarily
separated due to infant transfer to another facility in the
immediate postnatal period [32].
In this cohort of infants with consent to use DM, a
small but meaningful proportion (5%) of infants ultim-
ately never used DM and received their mother’s milk
exclusively. This scenario of anticipated need for supple-
mental milk without eventual need has been docu-
mented in the setting of large, multicenter randomized
controlled trials. In a Dutch trial comparing DM versus
formula to fill the gap when needed for feedings, 3.2% of
randomized infants received all feedings as MOM [33].
In a separate Canadian trial comparing DM and formula,
approximately 28% of infants ended up feeding only
their mother’s milk [34]. These subsets of infants and
their mothers appear worthy of attention in efforts to
define clinical scenarios in which a clinician may predict
the need for supplementation and yet ultimately there
was no need.
Approximately half of infants received formula at
some point during hospitalization. Feeding composition
during the first month suggests that formula use oc-
curred later in hospitalization when needed. High rates
of human milk feedings and later exposure to formula
may in part explain the low rates of NEC in this popula-
tion [8]. In comparison, overall rates of NEC for VLBW
infants cared for in the MMH NU are 1.6%.
The long-term implications of the measured growth
outcomes remain to be determined, although infant
growth rates act as surrogate markers of whether brain
development is optimal. Greater weight gain and head
growth during initial hospitalization were previously asso-
ciated with higher developmental testing scores in pre-
term infants [35]. Although length data were not available
for these infants, linear growth during hospitalization as
well as post discharge is a valid predictor of neurodevelop-
mental impairment in preterm infants [36].
Inherent limitations must be acknowledged related to
the retrospective study design, including missing data.
Also, despite considerable detail of nutrition and fluid
Table 5 Weekly intake for discharged infants with an admission duration ≥14 days, values reported as mean ± sd
Week 1 Week 2 Week 3 Week 4 p
Gestational age, < 32 weeks n = 39 n = 45 n = 45 n = 44
Fluid Intake, ml/kg/day 70 ± 29 172 ± 23 168 ± 23 169 ± 15 < 0.0001
Energy Intake, kcal/kg/day 47 ± 20 128 ± 20 129 ± 20 131 ± 14 < 0.0001
Gestational age, ≥ 32 weeks n = 25 n = 25 n = 24 n = 18
Fluid Intake, ml/kg/day 66 ± 32 158 ± 32 165 ± 37 160 ± 27 < 0.0001
Energy Intake, kcal/kg/day 45 ± 22 117 ± 25 125 ± 31 118 ± 25 < 0.0001
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intake during the first 28 days, daily intake throughout
hospitalization may have revealed additional nutritional
factors that contributed to the observed growth patterns.
Additionally, growth was only measured during the hos-
pital stay. Post discharge outcomes are necessary to draw
robust conclusions about any lasting implications of
early nutrition. This investigation was unable to identify
infants who may have qualified for DM feedings but par-
ental preference was to not provide consent. Similarly, we
could not ascertain reasons why parents may have pre-
ferred not to consent for DM in those scenarios. However,
clinicians in the MMH NU observe this to be an uncom-
mon occurrence. Regardless, a prospective investigation
examining the percentage of guardians choosing not to
consent for DM, their reasoning why, and how these in-
fants grow relative to those who do have signed consents
would be important for a comprehensive understanding of
the implications of DM feedings.
Conclusion
In conclusion, the use of DM for feeding infants managed
in a secondary South African Neonatal Unit was associ-
ated with suboptimal infant growth. As intended, DM
availability allows delayed exposure to formula and can
contribute to maintaining high proportions of human milk
feedings for high-risk infants. The consideration of all cir-
cumstances surrounding the nutritional management in
any single center appears vital to understanding how to
optimize infant outcomes associated with DM feedings.
Lactation support, relative amounts of a mother’s milk
availability and how MOM is handled prior to feedings
likely create unique and individual circumstances which
require attention during clinical and research efforts
aimed at improving feeding quality and infant outcomes.
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